$150.00 – $1,900.00
Buy ADB-FUBINACA online
ADB-FUBINACA is a designer drug identified in synthetic cannabis blends in Japan in 2013. The enantiomer of ADB-FUBINACA is claimed in Pfizer patent WO 2009/106982. However, it has been reported to be potent. Also, it is an agonist of the CB₁ receptor and CB₂ receptor with an EC₅₀ value of 1.2 nM and 3.5 nM respectively. It is a very popular cannabinoid.
Metabolism Of ADB-FUBINACA
Twenty-three ADB-FUBINACA major metabolites were identified in several incubations with cryopreserved human hepatocytes. However, the major metabolic pathways were alkyl and indazole hydroxylation, terminal amide hydrolysis, subsequent glucuronide conjugations, and dehydrogenation.
10g, 50g, 100g, 500g, 1000g